Compare VNRX & CREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VNRX | CREX |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.9M | 36.8M |
| IPO Year | 2012 | 2015 |
| Metric | VNRX | CREX |
|---|---|---|
| Price | $0.20 | $3.52 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $2.50 | N/A |
| AVG Volume (30 Days) | ★ 1.8M | 29.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.00 | 2.86 |
| EPS | ★ N/A | N/A |
| Revenue | $1,233,511.00 | ★ $18,437,000.00 |
| Revenue This Year | $68.22 | $11.51 |
| Revenue Next Year | $382.75 | $83.66 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 59.10 | 5.61 |
| 52 Week Low | $0.17 | $1.28 |
| 52 Week High | $0.94 | $4.00 |
| Indicator | VNRX | CREX |
|---|---|---|
| Relative Strength Index (RSI) | 42.45 | 55.91 |
| Support Level | $0.17 | $3.01 |
| Resistance Level | $0.27 | $3.86 |
| Average True Range (ATR) | 0.02 | 0.21 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 40.11 | 56.45 |
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
Creative Realities Inc, along with its subsidiaries, is engaged in providing digital marketing technology & solutions to world-wide retail companies, luxury and other individual retail brands, advertising networks, outdoor clients, enterprises, and other organizations. The Company operates in one reportable segment, marketing technology solutions. The company provides solutions related to digital merchandising systems, omnichannel customer engagement systems, interactive digital shopping assistants, advisors and kiosks, and high-end audio-visual networks along with marketing technologies such as mobile, social media, point-of-sale transactions, beaconing, and web-based media.